Back to Markets
SMSummit Therapeutics Inc

Summit Therapeutics Inc

SMMTNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$17.54

+0.1300 (+0.75%)

As of 05/29/26 EDT · USD

Compare
Low: $13.83Current: $17.54High: $30.98

Key Statistics

Open

$17.87

Day High

$18.51

Day Low

$17.36

Prev. Close

$17.41

VolumeShares traded today.

7.09M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$13.61B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-10.94

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$30.98

52W LowLowest price over the past 52 weeks.

$13.83

50D MAAverage closing price over the last 50 trading days.

$19.00

200D MAAverage closing price over the last 200 trading days.

$18.76

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+0.4%

1M

-15.8%

6M

-0.6%

YTD

+0.1%

1Y

-3.7%

About

Robert W. Duggan is an American billionaire entrepreneur, biotech and health care executive. He is the former CEO of biopharmaceutical company Pharmacyclics and was previously CEO of surgical systems maker Computer Motion from 1997 to 2003. Duggan is the majority shareholder and CEO of Pulse Biosciences and Summit Therapeutics.

www.smmttx.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade SMMT

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.